NO20030604L - Use of perfluoroalkyl-containing metal complexes as contrast agent in MR imaging to detect plaques, tumors and necrosis - Google Patents

Use of perfluoroalkyl-containing metal complexes as contrast agent in MR imaging to detect plaques, tumors and necrosis

Info

Publication number
NO20030604L
NO20030604L NO20030604A NO20030604A NO20030604L NO 20030604 L NO20030604 L NO 20030604L NO 20030604 A NO20030604 A NO 20030604A NO 20030604 A NO20030604 A NO 20030604A NO 20030604 L NO20030604 L NO 20030604L
Authority
NO
Norway
Prior art keywords
perfluoroalkyl
necrosis
tumors
imaging
contrast agent
Prior art date
Application number
NO20030604A
Other languages
Norwegian (no)
Other versions
NO20030604D0 (en
Inventor
Johannes Platzek
Peter Mareski
Ulrich Niedballa
Bernd Raduechel
Hanns-Joachim Weinmann
Bernd Misselwitz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10040380A external-priority patent/DE10040380B4/en
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20030604D0 publication Critical patent/NO20030604D0/en
Publication of NO20030604L publication Critical patent/NO20030604L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20030604A 2000-08-11 2003-02-07 Use of perfluoroalkyl-containing metal complexes as contrast agent in MR imaging to detect plaques, tumors and necrosis NO20030604L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040380A DE10040380B4 (en) 2000-08-11 2000-08-11 MRI contrast agent for visualization of plaque, lymph nodes, infarcted and necrotic tissue or both necrosis and tumors, comprising perfluoroalkylated metal complex having specific micelle forming properties
PCT/EP2001/008498 WO2002013874A2 (en) 2000-08-11 2001-07-23 Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses

Publications (2)

Publication Number Publication Date
NO20030604D0 NO20030604D0 (en) 2003-02-07
NO20030604L true NO20030604L (en) 2003-04-11

Family

ID=7652860

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030604A NO20030604L (en) 2000-08-11 2003-02-07 Use of perfluoroalkyl-containing metal complexes as contrast agent in MR imaging to detect plaques, tumors and necrosis

Country Status (26)

Country Link
EP (1) EP1307236A2 (en)
JP (1) JP2004506025A (en)
KR (1) KR20030022387A (en)
CN (1) CN1469757A (en)
AR (1) AR034139A1 (en)
AU (2) AU7754901A (en)
BG (1) BG107542A (en)
BR (1) BR0113188A (en)
CA (1) CA2419223A1 (en)
CZ (1) CZ2003392A3 (en)
DE (1) DE10066210B4 (en)
EE (1) EE200300061A (en)
HR (1) HRP20030173A2 (en)
HU (1) HUP0300736A3 (en)
IL (1) IL154385A0 (en)
MX (1) MXPA03001287A (en)
NO (1) NO20030604L (en)
NZ (1) NZ523932A (en)
PL (1) PL365596A1 (en)
RU (1) RU2290206C2 (en)
SK (1) SK1572003A3 (en)
TW (1) TWI296931B (en)
UA (1) UA82642C2 (en)
WO (1) WO2002013874A2 (en)
YU (1) YU10603A (en)
ZA (1) ZA200301949B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10231799B4 (en) * 2002-07-10 2006-10-05 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast agents in MR imaging for the presentation of intravascular thrombi
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
DE102005008309A1 (en) * 2005-02-17 2006-08-24 Schering Ag Pharmaceutical agents containing fluoroalkyl-containing metal complexes and epothilones
DE102006021495A1 (en) * 2006-05-09 2007-11-15 Bayer Schering Pharma Ag Use of metal chelate containing perfluorinated alkyl-residue, chelator-residue and metal ion equivalent to the atomic number, for the production of diagnostic agent for representation of amyloid-containing plaques
US7887835B2 (en) * 2006-09-19 2011-02-15 Fujifilm Corporation Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound
DE102006049821A1 (en) * 2006-10-18 2008-04-24 Bayer Schering Pharma Aktiengesellschaft New, well tolerated metal chelates, for use as radiodiagnostic, radiotherapeutic or NMR and X-ray diagnostic agents, contain chelator and perfluorinated polyethylene glycol residues
DE102007015598A1 (en) * 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Use of fluorochemical compounds for diagnostic purposes using imaging techniques
JP2011190183A (en) * 2010-03-11 2011-09-29 Noguchi Institute Fluorous sugar-bonded crown ether derivative
US9976072B2 (en) 2014-03-26 2018-05-22 Chevron U.S.A. Inc. Multicarboxylate compositions and method of making the same
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
US11104639B2 (en) 2016-09-14 2021-08-31 Daikin Industries, Ltd. Branched fluorine-containing compound
JP7034160B2 (en) 2016-11-28 2022-03-11 バイエル・ファルマ・アクティエンゲゼルシャフト High relaxation gadolinium chelate compound for use in magnetic resonance imaging
PE20211471A1 (en) 2018-11-23 2021-08-05 Bayer Ag FORMULATION OF CONTRAST MEANS AND PROCESS TO PREPARE THEM
CN109867635A (en) * 2019-02-14 2019-06-11 华东师范大学 A kind of T1 type micella magnetic resonance imaging contrast and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19603033A1 (en) * 1996-01-19 1997-07-24 Schering Ag Perfluoroalkyl-containing metal complexes, processes for their preparation and their use in NMR diagnostics
JPH10112939A (en) * 1996-10-07 1998-04-28 Nec Corp Power switching circuit
DE19729013A1 (en) * 1997-07-03 1999-02-04 Schering Ag Oligomeric, perfluoroalkyl-containing compounds, processes for their preparation and their use in NMR diagnostics
US6019959A (en) * 1997-07-31 2000-02-01 Schering Aktiengesellschaft Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis

Also Published As

Publication number Publication date
IL154385A0 (en) 2003-09-17
DE10066210B4 (en) 2008-02-28
SK1572003A3 (en) 2003-10-07
HUP0300736A3 (en) 2010-01-28
MXPA03001287A (en) 2003-10-06
BG107542A (en) 2003-09-30
JP2004506025A (en) 2004-02-26
HUP0300736A2 (en) 2003-09-29
TWI296931B (en) 2008-05-21
CZ2003392A3 (en) 2003-09-17
CN1469757A (en) 2004-01-21
WO2002013874A2 (en) 2002-02-21
BR0113188A (en) 2003-06-24
NO20030604D0 (en) 2003-02-07
NZ523932A (en) 2007-07-27
EP1307236A2 (en) 2003-05-07
AR034139A1 (en) 2004-02-04
CA2419223A1 (en) 2003-02-11
ZA200301949B (en) 2004-12-14
RU2290206C2 (en) 2006-12-27
HRP20030173A2 (en) 2005-04-30
KR20030022387A (en) 2003-03-15
AU2001277549B2 (en) 2007-02-08
WO2002013874A8 (en) 2002-06-13
EE200300061A (en) 2004-12-15
UA82642C2 (en) 2008-05-12
AU7754901A (en) 2002-02-25
YU10603A (en) 2006-05-25
PL365596A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
NO20030604D0 (en) Use of perfluoroalkyl-containing metal complexes as contrast agent in MR imaging to detect plaques, tumors and necrosis
AU2002339865A8 (en) Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
HK1110313A1 (en) Stilbene derivatives and their use for binding and imaging amyloid plaques
HK1146725A1 (en) Thioflavin derivatives for use in the diagnosis of alzheimers disease
CA2399358A1 (en) Pyrrole substituted 2-indolinone protein kinase inhibitors
WO2002029103A3 (en) Gene expression profiles in liver cancer
ZA200300545B (en) Novel heteroaryl derivatives and use thereof as anti-tumour agents.
WO2006066104A3 (en) Stilbene derivatives and their use for binding and imaging amyloid plaques
IS2485B (en) Phenylsulfonyl-1,3-dihydro-2H-indol-2-one derivatives, their preparation and therapeutic use
AU9086801A (en) Detection of microsatellite instability and its use in diagnosis of tumors
AU5133000A (en) Sodium magnetic resonance imaging used in diagnosing tumors and assessing response to treatment
AU2001277549A1 (en) Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses
IL163900A (en) Antibody which binds to tpte for use in diagnosing, monitoring, preventing or treating cancer disease and pharmaceutical compositions comprising said antibody
ZA200307306B (en) Indolines, substituted in portion 6, and their use as kinase inhibitors.
AU2001225150A1 (en) Paramagnetic dota derivatives, pharmaceutical agents containing the same, methods for the production thereof and their use for the mr imaging of necrosis and infarction
YU57803A (en) Use of il-18 inhibitors for the treatment and/or prevention of heart disease
CA2435320A1 (en) Compositions and methods for the use of fibronectin fragments in the diagnosis of cancer
JP2003503705A5 (en)
EE200300060A (en) Polar-containing perfluoroalkyl-containing complexes, process for their preparation and use
DK1519756T3 (en) Use of perfluoroalkyl-containing metal complexes as contrast agent in MRI imaging to display intravasal thrombi
IL152388A0 (en) Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
DK1292290T3 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
AU2003255991A1 (en) Catheter for use in mr imaging
HUP0301334A3 (en) Combined compositions against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolited
MXPA02012209A (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application